← Eichor
Study identifier: NCT07488039 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Labroplasty in Cases of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss

Condition: Recurrent Anterior Shoulder Instability  ·  Sponsor: Kasr El Aini Hospital

PhaseNA
Planned participants21
Who can joinAll sexes, 16 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn Labroplasty using the long head of biceps tendon works to patients with recurrent anterior shoulder instability with subcritical glenoid bone loss (\<20%) and thinned or deficient anterior labrum .The main questions it aims to answer are: Does Labroplasty using the long head of biceps improve the functional and radiological outcomes in patients with recurrent anterior shoulder instability with subcritical glenoid bone loss? Participants will: undergo arthroscopic labroplasty using the long head of biceps tendon Visit the clinic regularly for checkup and followup undergo MRI at 6 months to check radiological outcome

This description comes directly from the study's public registry record.

Talk to the study team

Sherif Walid Ibrahim, Assistant Lecturer  ·  +201271377782  ·  sherif_shibl@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Kasr El Aini HospitalCairo, Cairo Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07488039